Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Labeled Prospective Study to Investigate the Effect of Femarelle® on Vulvo-vaginal Atrophy Symptoms

NCT01502527 is registered in ClinicalTrials.gov with Dr. Lila Nachtigall Rapid Medical Research, New York as lead sponsor.

NCT NCT01502527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01502527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Labeled Prospective Study to Investigate the Effect of Femarelle® on Vulvo-vaginal Atrophy Symptoms
Lead sponsor
Dr. Lila Nachtigall Rapid Medical Research, New York
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
March 31, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvo vaginal atrophy